Skye Bioscience Inc. is pioneering a way to unlock the pharmaceutical potential of cannabinoids
Deep Dive - Skye Bioscience Inc
Source: proactiveinvestors.com
📰 Skye Bioscience News
Page 11 - Skye Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Skye Bioscience. Real-time updates on events, politics, business and more.
US stocks end higher after a volatile day
4.02pm: US market closes in the green The US indices ended higher at the end of a volatile day as investors await quarterly earnings from Alphabet later in...
Source: proactiveinvestors.com
US stocks waiver as investors weigh jobs and manufacturing data
4.02pm: US market closes in the green The US indices ended higher at the end of a volatile day as investors await quarterly earnings from Alphabet later in...
Source: proactiveinvestors.com
Skye Bioscience Inc reports potential neuroprotective benefit of SBI-100 in preclinical glaucoma model
Skye Bioscience inc (OTCQB:SKYE) announced that in a preclinical study assessing the neuroprotective properties of its SBI-100 ophthalmic nanoemulsion, the...
Source: proactiveinvestors.com
NA Proactive news snapshot: Talon Metals Corp, Gratomic Inc, Skye Bioscience Inc, Universal Ibogaine Inc, Todos Medical Ltd, Burcon NutraScience Corp, Genprex Inc, Ximen Mining Corp, Think Research Corporation, Hawkmoon Resources Corp UPDATE ...
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
Source: proactiveinvestors.com
Skye Bioscience Inc CEO Punit Dhillon says company 'fast approaching' first-in-human Phase I study in 2022 for SBI-100
For 2022, Dhillon told investors that the company is preparing to make significant headway with the clinical development of SBI-100, the...
Source: proactiveinvestors.com
Skye BioScience (OTCMKTS:SKYE) Presenting at the Proactive One2One Virtual Forum
We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant...
Source: proactiveinvestors.co.uk
Skye BioScience (OTCMKTS:SKYE) Presenting at the Proactive One2One Virtual Forum
We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant...
Source: proactiveinvestors.com
Skye Bioscience present pipeline of assets using cannabinoid-derived molecules to treat glaucoma
Skye Bioscience inc (OTCQB:SKYE)s (OTCQB:SKYE) Punit Dhillon talks to Proactive London about the companys cannabinoid-derived molecules to...
Source: proactiveinvestors.com
Skye Bioscience present pipeline of assets using cannabinoid-derived molecules to treat glaucoma
Skye Bioscience inc (OTCQB:SKYE)s (OTCQB:SKYE) Punit Dhillon talks to Proactive London about the companys cannabinoid-derived molecules to...
Source: proactiveinvestors.co.uk